Suppression of myeloid cell arginase activity leads to therapeutic response in Kras mutant lung cancer by activating anti-tumor immunity

被引：0
|
作者：
Miret, Juan J. [1 ]
Kirschmeier, Paul [1 ]
Wu, Min [1 ]
Huang, Wei [1 ]
Walker, William [1 ]
Palakurti, Sangeetha [1 ]
Saccomano, Nick [2 ]
Hammerman, Peter S. [1 ]
Wong, Kwok-Kin [3 ]
Akbay, Esra [4 ]
机构：
[1] Dana Farber Canc Inst, Belfer Inst, Boston, MA 02115 USA
[2] Array Biopharma, Boulder, CO USA
[3] NYU, Div Hematol & Med Oncol, Boston, MA USA
[4] UT Southwestern Med Ctr, Dallas, TX USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4065
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
    Miret, Juan J.
    Kirschmeier, Paul
    Koyama, Shohei
    Zhu, Mingrui
    Li, Yvonne Y.
    Naito, Yujiro
    Wu, Min
    Malladi, Venkat S.
    Huang, Wei
    Walker, William
    Palakurthi, Sangeetha
    Dranoff, Glenn
    Hammerman, Peter S.
    Pecot, Chad V.
    Wong, Kwok-Kin
    Akbay, Esra A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Pulsatile MEK inhibition improves anti-tumor immunity and T cell function in Kras mutant lung cancer
    Choi, Hyejin
    Deng, Jiehui
    Li, Shuai
    Silk, Tarik
    Dong, Lauren
    Brea, Elliott J.
    Houghton, Sean
    Redmond, David
    Zhong, Hong
    Boiarsky, Jonathan
    Akbay, Esra A.
    Smith, Paul D.
    Merghoub, Taha
    Wong, Kwok-Kin
    Wolchok, Jedd D.
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer
    Choi, Hyejin
    Deng, Jiehui
    Li, Shuai
    Silk, Tarik
    Dong, Lauren
    Brea, Elliott J.
    Houghton, Sean
    Redmond, David
    Zhong, Hong
    Boiarsky, Jonathan
    Akbay, Esra A.
    Smith, Paul D.
    Merghoub, Taha
    Wong, Kwok-Kin
    Wolchok, Jedd D.
    CELL REPORTS, 2019, 27 (03): : 806 - +
  • [4] Anti-tumor immunity is a key determinant of small cell lung cancer survivorship
    Kosari, Farhad
    Muppa, Prasuna
    Terra, Simone
    Sharma, Anurag
    Mansfield, Aaron
    Aubry, Marie Christine
    Janaki, Nafiseh
    Nasir, Aqsa
    Peikert, Tobias
    CANCER RESEARCH, 2019, 79 (13)
  • [5] TELOMERE DYSFUNCTION MEDIATES ANTI-TUMOR IMMUNITY IN SMALL CELL LUNG CANCER
    Zhu, Mingrui
    Eglenen-Polat, Buse
    Bender, Matthew
    Mender, Ilgen
    Siteni, Silvia
    Drapkin, Benjamin
    Shay, Jerry
    Akbay, Esra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A944 - A944
  • [6] SOX9 Drives KRAS-Induced Lung Adenocarcinoma Progression Through Suppression of Anti-Tumor Immunity
    Pine, S. R.
    Zhong, H.
    Menon, D. Ravindran
    Ganesan, S.
    Sabaawy, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S87 - S87
  • [7] Enhanced anti-tumor activity through targeted immunotherapy combined with mutant KRAS inhibition in pancreatic cancer
    Creech, Amanda
    Lee, Hailey
    Rashid, Khalid
    Le, Thuc
    Premji, Alykhan
    Luu, Tony
    Kassem, Ahmad
    Zhao, Weihang
    Li, Luyi
    Wu, Nanping
    Pardi, Norbert
    Wohlschlegel, James
    Donahue, Timothy
    Radu, Caius
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [8] B cell regulation in cancer and anti-tumor immunity
    Anushruti Sarvaria
    J Alejandro Madrigal
    Aurore Saudemont
    Cellular & Molecular Immunology, 2017, 14 : 662 - 674
  • [9] Role of CD38 in anti-tumor immunity of small cell lung cancer
    Taniguchi, Hirokazu
    Chavan, Shweta S.
    Chow, Andrew
    Chan, Joseph M.
    Mukae, Hiroshi
    Rudin, Charles M.
    Sen, Triparna
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Dissecting tumor cell heterogeneity to identify therapeutic vulnerabilities in Kras-mutant lung cancer.
    Padhye, Aparna
    Rodriguez, B. Leticia
    Fradette, Jared J.
    Ungewiss, Christin
    Gibbons, Don L.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 55 - 55
12345